€93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> Vaccines Could Help Reduce Asymptomatic Virus Transmission – Although More Evidence Is Needed 06/01/2021 Raisa Santos Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> Vaccines Could Help Reduce Asymptomatic Virus Transmission – Although More Evidence Is Needed 06/01/2021 Raisa Santos Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
UK Approves Moderna Vaccine, With Caveat Of Spring Rollout 08/01/2021 J Hacker The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading -> Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> Vaccines Could Help Reduce Asymptomatic Virus Transmission – Although More Evidence Is Needed 06/01/2021 Raisa Santos Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
Countries Around World Lockdown Economies To Fight New Coronavirus Variants 06/01/2021 Raisa Santos & J Hacker After brief holiday respites, countries in Europe, Asia, the Middle East and Africa have reverted to major lockdowns as a strategy to stave off new, and even more infectious, SARS-CoV2 virus variants that have been identified in the United Kingdom and in South Africa – which threaten to overwhelm health systems even as countries also […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> Vaccines Could Help Reduce Asymptomatic Virus Transmission – Although More Evidence Is Needed 06/01/2021 Raisa Santos Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> Vaccines Could Help Reduce Asymptomatic Virus Transmission – Although More Evidence Is Needed 06/01/2021 Raisa Santos Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
Vaccines Could Help Reduce Asymptomatic Virus Transmission – Although More Evidence Is Needed 06/01/2021 Raisa Santos Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts
India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data 04/01/2021 Menaka Rao Delhi – India’s chief drug regulator approved two COVID-19 vaccines for “restricted emergency use” in the country on Sunday, opening the doors for a mass vaccination campaign against COVID to begin in one of the world’s largest countries, and a lower middle-income country at that. However, some watchdog groups said that the review process leading […] Continue reading -> Posts navigation Older postsNewer posts